Home » Resource Hub » Research » CTAC Submission to the Canadian Agency for Drugs and Technologies in Health: Egrifta CTAC Submission to the Canadian Agency for Drugs and Technologies in Health: Egrifta Conference Year 2016 Patient & caregiver experience on the use of EGRIFTA for treatment of Lipodystrophy in HIV inefected patients Open Source: CTAC (Canadian Treatment Action Council)